Bone is a common site for metastasis from malignant neoplasms. Metastatic disease to bone is found post-mortem in 50--80% of patients who succumb to their disease. The femur is one of the most common reasons patients with carcinoma present to an orthopaedic surgeon. Improvements in nonoperative management have decreased the need for surgical intervention in many metastatic lesions. However, in the femur, a large weight bearing long bone, surgery is still often indicated. The choice of surgical treatment often varies with surgeon preference, with no set gold standard. Patient comorbidities and risk of perioperative complications must be taken into account and each implant comes with its own set of risks and benefits. Other less invasive procedures, i.e. cementoplasty, have worked well in the spine. However, use in the femur is questionable and patient comorbidities and goals should be taken into account before its use. Whatever, if any, surgical intervention is used in treatment of metastatic lesions, radiation and bisphosphonate should be used unless contraindicated.
CONCLUSIONWithin the last few years, there have been some challenges to standard practice, i.e. cemented versus uncemented stems, splinting the entire bone, and so forth. More research FIGURE 2. A 60-year-old man with multiple myeloma sustained a subtrochanteric fracture through a pathologic lesion after a low-energy fall. Radiographs show fracture and immediate postoperative images.552 | www.c-orthopaedicpractice.com Volume